Moore Capital Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-70,000
Closed -$14.9M – 579
2023
Q3
$14.9M Buy
70,000
+58,000
+483% +$11.6M 0.28% 70
2023
Q2
$2.31M Sell
12,000
-8,000
-40% -$1.59M 0.04% 242
2023
Q1
$4.05M Buy
+20,000
New +$3.21M 0.09% 186
2022
Q3
– Sell
-15,825
Closed -$2.8M – 765
2022
Q2
$2.8M Sell
15,825
-121,177
-88% -$17.5M 0.07% 279
2022
Q1
$19.7M Sell
137,002
-33,964
-20% -$4.6M 0.5% 29
2021
Q4
$26.4M Buy
170,966
+22,918
+15% +$3.84M 0.52% 34
2021
Q3
$25.1M Sell
148,048
-20,767
-12% -$3.23M 0.38% 58
2021
Q2
$26.7M Buy
168,815
+69,899
+71% +$10.4M 0.38% 61
2021
Q1
$13.7M Buy
+98,916
New +$15.9M 0.17% 102

Other funds holding SGEN

Moore Capital Management's SGEN Position: Q4 2023 in Review

Moore Capital Management sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 70,000 shares — an estimated $14.9M sold.

Moore Capital Management first reported a position in SGEN in Q1 2021 and held it in 9 quarters. The position peaked at $26.7M in Q2 2021. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Moore Capital Management reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Moore Capital Management sold 70,000 Seagen Inc. Common Stock shares in Q4 2023, an estimated $14.9M.
  • Moore Capital Management first reported a position in Seagen Inc. Common Stock in Q1 2021 and held it in 9 quarters.
  • Moore Capital Management's Seagen Inc. Common Stock position peaked at $26.7M in Q2 2021.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Moore Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.